General Information of Drug Off-Target (DOT) (ID: OT0CA0GF)

DOT Name Nucleoside diphosphate kinase 3 (NME3)
Synonyms NDK 3; NDP kinase 3; EC 2.7.4.6; DR-nm23; Nucleoside diphosphate kinase C; NDPKC; nm23-H3
Gene Name NME3
Related Disease
Colorectal carcinoma ( )
Neoplasm ( )
Adult glioblastoma ( )
Breast carcinoma ( )
Cardiac failure ( )
Ciliopathy ( )
Congestive heart failure ( )
Epithelial ovarian cancer ( )
Glioblastoma multiforme ( )
Ovarian cancer ( )
Ovarian neoplasm ( )
Neuroblastoma ( )
UniProt ID
NDK3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1ZS6
EC Number
2.7.4.6
Pfam ID
PF00334
Sequence
MICLVLTIFANLFPAACTGAHERTFLAVKPDGVQRRLVGEIVRRFERKGFKLVALKLVQA
SEELLREHYAELRERPFYGRLVKYMASGPVVAMVWQGLDVVRTSRALIGATNPADAPPGT
IRGDFCIEVGKNLIHGSDSVESARREIALWFRADELLCWEDSAGHWLYE
Function
Catalyzes the phosphorylation of ribonucleosides and deoxyribonucleoside diphosphates, other than ATP, into the corresponding triphosphates with ATP as the major phosphate donor. The ATP gamma phosphate is transferred to the nucleoside diphosphate beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Through the catalyzed exchange of gamma-phosphate between di- and triphosphonucleosides participates in regulation of intracellular nucleotide homeostasis. Inhibits granulocyte differentiation. May be required for ciliary function during renal development; Independently of its kinase activity, facilitates mitochondrial tethering prior to membrane fusion through its direct membrane-binding and hexamerization. Implicated in repair of both single- and double-stranded breaks in DNA through its association with the ribonucleotide reductase complex (RNR complex) via its interaction with the histone acetyltransferase KAT5, this interaction enables recruitment of NME3 at DNA damage sites where it plays a role in the repair of DNA, independently of its kinase activity.
KEGG Pathway
Purine metabolism (hsa00230 )
Pyrimidine metabolism (hsa00240 )
Drug metabolism - other enzymes (hsa00983 )
Metabolic pathways (hsa01100 )
Nucleotide metabolism (hsa01232 )
Biosynthesis of cofactors (hsa01240 )
Reactome Pathway
Interconversion of nucleotide di- and triphosphates (R-HSA-499943 )

Molecular Interaction Atlas (MIA) of This DOT

12 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Colorectal carcinoma DIS5PYL0 Definitive Biomarker [1]
Neoplasm DISZKGEW Definitive Altered Expression [1]
Adult glioblastoma DISVP4LU Strong Altered Expression [2]
Breast carcinoma DIS2UE88 Strong Altered Expression [2]
Cardiac failure DISDC067 Strong Biomarker [3]
Ciliopathy DIS10G4I Strong Biomarker [4]
Congestive heart failure DIS32MEA Strong Altered Expression [3]
Epithelial ovarian cancer DIS56MH2 Strong Altered Expression [5]
Glioblastoma multiforme DISK8246 Strong Altered Expression [2]
Ovarian cancer DISZJHAP Strong Altered Expression [5]
Ovarian neoplasm DISEAFTY Strong Altered Expression [5]
Neuroblastoma DISVZBI4 Limited Biomarker [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Afimoxifene DMFORDT Phase 2 Nucleoside diphosphate kinase 3 (NME3) decreases the response to substance of Afimoxifene. [20]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Nucleoside diphosphate kinase 3 (NME3). [7]
------------------------------------------------------------------------------------
13 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [8]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [9]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [10]
Temozolomide DMKECZD Approved Temozolomide increases the expression of Nucleoside diphosphate kinase 3 (NME3). [11]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Nucleoside diphosphate kinase 3 (NME3). [12]
Nicotine DMWX5CO Approved Nicotine decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [13]
Menthol DMG2KW7 Approved Menthol decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [14]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [15]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [13]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [16]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [17]
THAPSIGARGIN DMDMQIE Preclinical THAPSIGARGIN decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [18]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Nucleoside diphosphate kinase 3 (NME3). [19]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)

References

1 Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer.Eur J Cancer Prev. 2013 Nov;22(6):512-22. doi: 10.1097/CEJ.0b013e328361625d.
2 Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.Cancer Res. 1997 Mar 15;57(6):1180-7.
3 Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart Failure.Circulation. 2017 Feb 28;135(9):881-897. doi: 10.1161/CIRCULATIONAHA.116.022852. Epub 2016 Dec 7.
4 The nucleoside-diphosphate kinase NME3 associates with nephronophthisis proteins and is required for ciliary function during renal development.J Biol Chem. 2018 Sep 28;293(39):15243-15255. doi: 10.1074/jbc.RA117.000847. Epub 2018 Aug 15.
5 Nucleoside Diphosphate Kinase-3 (NME3) Enhances TLR5-Induced NFB Activation.Mol Cancer Res. 2018 Jun;16(6):986-999. doi: 10.1158/1541-7786.MCR-17-0603. Epub 2018 Mar 9.
6 DR-nm23 gene expression in neuroblastoma cells: relationship to integrin expression, adhesion characteristics, and differentiation.J Natl Cancer Inst. 1997 Sep 3;89(17):1300-10. doi: 10.1093/jnci/89.17.1300.
7 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
8 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
9 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
10 Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells. Br J Pharmacol. 2013 May;169(1):167-78.
11 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
12 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
13 Effects of tobacco compounds on gene expression in fetal lung fibroblasts. Environ Toxicol. 2008 Aug;23(4):423-34.
14 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
15 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
16 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
17 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
18 Chemical stresses fail to mimic the unfolded protein response resulting from luminal load with unfolded polypeptides. J Biol Chem. 2018 Apr 13;293(15):5600-5612.
19 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
20 High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2058-63.